DocDollars

Tersera Therapeutics LLC

IL · United States · Reporting entity ID 100000181761

Total reported 2019–2025
$10.5M
#477 of 2,960 reporting companies — 0% of all reported industry payments
$4.93M in general payments across 33,813 records, plus $3.78M in research funding across 495 records.

How it breaks down

General payments $4,928,579
Research funding $3,779,086
Ownership & investment $1,778,328

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Tersera Therapeutics LLC reported $10.5M to US doctors and teaching hospitals from 2019 to 2025, ranking #477 of 2,960 reporting companies. 36% of that was research funding and 64% general payments such as consulting, speaking, food and travel. 33,813 general payment records and 495 research records were filed.

Common questions about Tersera Therapeutics LLC

How much has Tersera Therapeutics LLC paid US doctors?

Tersera Therapeutics LLC reported $10,485,992 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $4,928,579 in general payments, $3,779,086 in research funding and $1,778,328 in ownership and investment interests.

How does Tersera Therapeutics LLC rank among drug and device companies?

It ranks #477 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Tersera Therapeutics LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.